JASON ROBERT WESTIN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Randomized Controlled Trials as Topic.
Connection Strength
0.038
-
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017 10 19; 130(16):1800-1808.
Score: 0.021
-
Accelerated therapeutic progress in diffuse large B cell lymphoma. Ann Hematol. 2014 Apr; 93(4):541-56.
Score: 0.017